IZALONTAMAB

UNII:	S8YH2C9NLA
Formula:
Preferred Substance Name:	IZALONTAMAB
GSRS Full Record:	S8YH2C9NLA i

2559704-24-2
ANTI-EGFR/HER3 BISPECIFIC ANTIBODY SI-B001
HER3 X EGFR SI-B001
IMMUNOGLOBULIN G1 (DE-448-LYSINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER3) (HUMAN CLONE HER3.H3 SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)3-VL), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
IZALONTAMAB [INN]
IZALONTAMAB [USAN]
IZALONTAMAB [WHO-DD]
SI-B001

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

IZALONTAMAB

Synonyms and Mappings

Resources